1. Current good manufacturing practice for positron emission tomography drugs. Fed Regist. 2009;74:65409. To be codified at 21 CFR §210, 211, and 212.
2. Current good manufacturing practice for positron emission tomography drugs: preliminary draft proposed rule. Fed Regist. 1995;60:10594.
3. Food and Drug Modernization Act of 1997. U.S. Food and Drug Administration website. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDAMA/FullTextofFDAMAlaw/default.htm. Updated October 22, 2009. Accessed May 8, 2014.
4. Positron emission tomography drug products; safety and effectiveness of certain PET drugs for specific indications. Fed Regist. 2000;65:12999–13010.
5. Guidance on current good manufacturing practice for positron emission tomography drugs; availability. Fed Regist. 2009;74:65538.